Children with Down syndrome reportedly have a high prevalence of nystagmus. [1] [2] [3] The etiology of nystagmus in Down syndrome has been presumed to be idiopathic, although evidence for this is limited. Whether cerebellar hypoplasia, a common magnetic resonance imaging (MRI) finding in Down syndrome, contributes to nystagmus has been investigated recently because of the role of the cerebellum on gaze-holding mechanisms within the brain. 4 We sought to report the prevalence of nystagmus in a large cohort of patients with Down syndrome and to determine whether underlying progressive neurologic disease contributes to nystagmus.
syndrome with a clinical diagnosis of nystagmus had neuroimaging, and in no case was a progressive neurologic process found to explain the presence of nystagmus. Three of these children were noted to have cerebellar hypoplasia.
Other studies have shown rates of nystagmus in patients with Down syndrome similar to our study's prevalence of 17%. For example, da Cunha and Moreira 5 demonstrated 18% prevalence in a cohort of 152 children with Down syndrome, and Stephen et al. 6 described 16% prevalence in a cohort of 72 patients. To date, we report the prevalence of nystagmus in the largest cohort of pediatric patients with Down syndrome of which we are aware.
Nystagmus in pediatric patients with Down syndrome can prompt the question as to whether or not imaging is warranted. Neuroimaging is not entirely without risk in this population. There are risks related to sedation, side effects of dye used to enhance imaging, and potential exposure to radiation with CT. In our cohort, neuroimaging did not reveal any underlying progressive neurologic process as the basis for nystagmus. In the absence of other focal neurologic signs or indications, neuroimaging to exclude progressive neurologic disease as a cause of nystagmus may be of low yield in the population with Down syndrome.
